World's Best Scientists 2026 revealed!
Haematologica
H-index 64

Haematologica

0390-6078

Published by: Ferrata Storti Foundation

https://haematologica.org/index

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 152 886 1254 59

Additional Metrics

Number of Best Scientists*: 1583
Documents by Best Scientists*: 1631
Top 100 Ranked Scientists*: 44
SCIMAGO H-index: 172
SCIMAGO SJR: 2.449
Impact Factor: 7.9

Overview

Top Research Topics at Haematologica?

Haematologica mostly deals with topics like Internal medicine, Immunology, Cancer research, Pathology and Oncology. Internal medicine research presented in it encompasses a variety of subjects, including Gastroenterology, Endocrinology and Surgery. In particular, the Surgery works presented emphasize discussions on Chemotherapy.

The concepts on Immunology presented in it can also apply to other research fields, including Hematopoietic stem cell transplantation, Disease and Transplantation. It dives deep in exploring the relationship between the study of Transplantation and Stem cell. Stem cell research is concerned with Haematopoiesis in particular.

Bone marrow and Lymphoma are among the concentrations of Pathology that garnered much attention in Haematologica. The journal focuses on Oncology research which is adjacent to topics in Multiple myeloma. Haematologica holds forums on Leukemia that merges themes from other disciplines such as Myeloid and Myeloid leukemia.

  • Internal medicine (33.93%)
  • Immunology (23.06%)
  • Cancer research (15.51%)

What are the most cited papers published in the journal?

  • Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine (866 citations)
  • The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. (712 citations)
  • Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials (637 citations)

Research areas of the most cited articles at Haematologica:

The most cited papers cover a variety of subjects, including Internal medicine, Immunology, Surgery, Hematology and Leukemia. The works on Internal medicine tackled in the most cited publications bring together disciplines like Gastroenterology and Oncology. In addition to Leukemia research, the most cited publications aim to explore topics under Myeloid, Cancer research and Myeloid leukemia.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

The topics of Internal medicine, Cancer research, Oncology, Text mining and Myeloid leukemia are the focal point of discussions in Haematologica. Some problems in Internal medicine that were presented in it overlapped with concepts under Gastroenterology and MEDLINE. MEDLINE study tackled is connected to the field of Intensive care medicine.

Issues in Cancer research were discussed, taking into consideration concepts from other disciplines like Ex vivo, Downregulation and upregulation, Bone marrow and Leukemia, Chronic lymphocytic leukemia. The studies on Oncology discussed can also contribute to research in the domains of Regimen, Lymphoblastic Leukemia, Multiple myeloma and Rituximab.

The most cited articles from the last journal are:

  • Antibody-mediated procoagulant platelets in SARS-CoV-2- vaccination associated immune thrombotic thrombocytopenia. (17 citations)
  • A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis (10 citations)
  • APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Haematologica (based on the number of publications) are:

  • Franco Mandelli (120 papers) absent at the last edition,
  • Tura S (109 papers) absent at the last edition,
  • Michele Baccarani (108 papers) absent at the last edition,
  • Giovanni Martinelli (108 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Mario Cazzola (105 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Haematologica (based on the number of publications) are:

  • University of Pavia (358 papers) published 9 papers at the last edition, 5 less than at the previous edition,
  • University of Bologna (311 papers) published 3 papers at the last edition, 6 less than at the previous edition,
  • University of Milan (299 papers) published 6 papers at the last edition, 19 less than at the previous edition,
  • Boston Children's Hospital (293 papers) published 7 papers at the last edition, 21 less than at the previous edition,
  • Sapienza University of Rome (272 papers) published 5 papers at the last edition, 13 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.33% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.46% were posted by at least one author from the top 10 institutions publishing in the journal. Another 19.16% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.09% of all publications and 43.30% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Relation Between Haematologica Research and Other Fields

In addition to the fields directly mentioned in Haematologica, there are observable interconnections between its research and other domains of study. This intersectionality fosters a wealth of knowledge diversity within the journal, further propelling pioneering advancements in medicine and life sciences.

Notably, the studies and articles on Oncology, Internal Medicine, and Immunology often extend their relevance to areas such as Nursing. Nursing is a critical healthcare profession whose practices can be significantly enhanced by the findings in Haematologica, particularly in the context of patient care in the Oncology and Internal Medicine departments. Recent leaps in Immunology in particular have profound implications on how nursing practices adapt to an ever-evolving understanding of diseases.

Many nurses who wish to maintain currency in these fast-evolving areas of medical science choose to supplement their practice with advanced nursing degrees. In particular, aspiring nursing professionals in Colorado often take interest in these fields as part of their curriculum. To navigate this path more clearly, they can refer to a collection of the best nursing schools in Colorado. By doing so, they stand in a better position to incorporate these research advancements from Haematologica into their healthcare service delivery.

Top Publications

  • Pediatric acute lymphoblastic leukemia.

    Hiroto Inaba;Charles G. Mullighan

    (2020)
    379 Citations
  • Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    Ibrahim Yakoub-Agha;Christian Chabannon;Peter Bader;Grzegorz W. Basak

    (2020)
    362 Citations
  • International recommendations on the diagnosis and treatment of acquired hemophilia A

    Andreas Tiede;Peter Collins;Paul Knoebl;Jerome Teitel

    (2020)
    280 Citations
  • Hemophilia therapy: the future has begun

    Pier Mannuccio Mannucci

    (2020)
    183 Citations
  • Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.

    Cesare Perotti;Fausto Baldanti;Raffaele Bruno;Claudia Del Fante

    (2020)
    158 Citations
  • Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women

    Nicole U. Stoffel;Christophe Zeder;Gary M. Brittenham;Diego Moretti

    (2020)
    153 Citations
  • Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease

    Gaurav Goyal;Aishwarya Ravindran;Jason R. Young;Mithun V. Shah

    (2020)
    146 Citations
  • One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

    Dietger Niederwieser;Helen Baldomero;Nosa Bazuaye;Caitrin Bupp

    (2021)
    145 Citations
  • First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

    (2022)
    141 Citations
  • Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

    Heikki Kuusanmäki;Aino-Maija Leppä;Petri Pölönen;Mika Kontro

    (2020)
    133 Citations

Related Online Degrees & Career Pathways

Exploring alternative or complementary fields related to Medicine can open diverse career opportunities. Many students with a background in healthcare consider a range of options that build on their foundational knowledge. For example, exploring biology major careers offers insights into various roles in research, healthcare, and pharmaceuticals, which can be highly rewarding and financially viable.

For those interested in the administrative side of healthcare, obtaining a ccs certification can be a game changer. This certification enhances a professional’s qualifications for more advanced medical coding roles that generally come with better pay and responsibilities.

Understanding how much does a medical coder make also plays a crucial role for those considering this pathway, as compensation can vary based on certification, experience, and location. Medical coders are in demand, but it’s important to research earning potential before committing.

Finally, the medical billing and coding job outlook remains strong, supported by the ongoing need for skilled professionals to navigate insurance and healthcare documentation. Understanding both the benefits and challenges of this career helps students make informed decisions about their futures in the healthcare industry.

Best Scientists Contributing to This Journal

Recently Published Articles